CRH Appoints New CFO Aylwyn Bryan
CRH PLC's stock fell 3.09% as it hit a 20-day low amid broader market gains in the Nasdaq-100 and S&P 500.
The company announced the appointment of Aylwyn Bryan as the new CFO, succeeding Nancy Buese, who stepped down by mutual agreement. Bryan's extensive experience at CRH is expected to enhance financial leadership. Additionally, CRH forecasts adjusted EBITDA of $8.1 billion to $8.5 billion for 2026, reflecting strong performance in M&A activity and margin expansion, indicating the company's competitiveness and growth potential in the industry.
The leadership transition aims to ensure stability in financial reporting and operations, which may help mitigate risks associated with executive turnover, while the strategic investment in the $700 million Axius Water deal further strengthens CRH's market position.
Trade with 70% Backtested Accuracy
Analyst Views on CRH
About CRH
About the author

- LCI Merger Investigation: LCI Industries is set to be acquired by Patrick Industries in an all-stock deal where LCI shareholders will receive 1.2440 shares of Patrick for each LCI share, raising concerns about whether the LCI Board breached its fiduciary duties by failing to ensure fair pricing, potentially impacting shareholder value.
- Iridium Acquisition Scrutiny: Iridium Communications will be acquired by Rocket Lab for $54 per share in a cash and stock transaction, representing an enterprise value of approximately $8 billion, with investigations questioning whether the Iridium Board adequately protected shareholder interests during the deal process, risking fair value for shareholders.
- Bio-Techne Merger Review: Bio-Techne Corporation is to be acquired by Merck KGaA for $73 per share in cash, totaling an enterprise value of around $11.3 billion, with investigations focusing on whether the Bio-Techne Board conducted a fair process, potentially affecting shareholder returns.
- Arcosa Merger Investigation: Arcosa will be acquired by CRH for $150 per share in cash, with an enterprise value of approximately $8.5 billion, raising questions about whether the Arcosa Board fulfilled its fiduciary duties to shareholders, possibly leading to inadequate valuation in the transaction.
- LCI Merger Investigation: LCI Industries is set to be acquired by Patrick Industries in an all-stock deal where shareholders will receive 1.2440 shares of Patrick for each LCI share, with investigations questioning whether the LCI Board breached fiduciary duties by failing to ensure a fair process.
- Iridium Acquisition Details: Iridium Communications will be acquired by Rocket Lab for $54 per share in a cash and stock transaction, representing an enterprise value of approximately $8 billion, with investigations focusing on whether the Iridium Board adequately protected shareholder interests during the process.
- Bio-Techne Merger Review: Bio-Techne Corporation is to be acquired by Merck KGaA for $73 per share in cash, totaling an enterprise value of about $11.3 billion, with investigations examining whether the Bio-Techne Board conducted a fair process to ensure shareholders receive fair value.
- Arcosa Acquisition Inquiry: Arcosa will be acquired by CRH for $150 per share in cash, with an enterprise value of approximately $8.5 billion, and investigations questioning whether the Arcosa Board fulfilled its fiduciary duties to ensure fair value for shareholders.
- Market Rally: The S&P 500 and Nasdaq are on track to end a five-session losing streak on Monday, indicating a rebound in market sentiment, particularly with Amazon, Alphabet, and Meta Platforms leading the recovery, which could boost investor confidence.
- Healthcare Sector Surge: Corning and Palo Alto Networks reached all-time highs during Monday's session, reflecting a resurgence in the healthcare sector, which may attract more capital into this previously undervalued area, further driving industry growth.
- Executive Changes Impact: Goldman Sachs served as the exclusive financial advisor for Martin Marietta's $13.5 billion acquisition of Lhoist North America and provided fully committed debt financing, showcasing its strong performance in investment banking, which could enhance its market position.
- Economic Data Focus: This week will see the release of the consumer confidence survey and the JOLTS report, which are expected to influence market sentiment, especially ahead of the upcoming non-farm payroll report, prompting investors to closely monitor these economic indicators.
- Market Recovery: S&P 500 and Nasdaq futures are up this morning, recovering some of last week's losses after the U.S. and Iran agreed to halt military strikes, which is expected to ease geopolitical tensions and potentially boost market sentiment.
- Honeywell Spin-off: Honeywell has completed the spin-off of its aviation and defense business into a standalone company called Honeywell Aerospace (HONA), receiving a buy rating and a $306 price target from Melius, indicating strong market confidence in its future growth prospects.
- Space Industry Deal: Rocket Lab is acquiring Iridium Communications in a cash-and-stock deal valued at approximately $8 billion, which is expected to be a transformative deal in the space industry, enhancing Rocket Lab's market position and expanding its business capabilities.
- Semiconductor Price Target Adjustments: Cantor Fitzgerald raised price targets on several semiconductor stocks, including Micron and Applied Materials, reflecting an optimistic outlook on the semiconductor industry's recovery, which may attract more investor interest in the sector.
- Preference Share Cancellation: CRH announced that the schemes to cancel its 5% and 7% preference shares became effective on June 25, 2026, marking a significant adjustment in the company's capital structure that may impact investor confidence.
- Trading Suspension Notice: The 5% preference shares are expected to cease trading on Euronext Growth Dublin at 7:00 a.m. (BST) on June 26, 2026, which will reduce market liquidity and could exert short-term pressure on the stock price.
- Company Background: CRH is a leading provider of building materials critical for modernizing infrastructure, employing 83,000 people across 4,000 locations, showcasing its substantial scale and market influence in the industry.
- Strategic Implications: The cancellation of preference shares may provide CRH with greater financial flexibility to support investments in transportation, water, and reindustrialization projects, further solidifying its market leadership.
- Product Innovation: PebbleTec has launched three new products, PebbleShield, TileTrim, and Slurry Saver, aimed at enhancing pool installation efficiency and quality to meet the market demand for high-quality pool finishes.
- PebbleShield Benefits: PebbleShield, a new additive, densifies and strengthens the cement matrix, virtually eliminating plaster dust during application, which is expected to significantly reduce project turnover time and improve overall work efficiency.
- TileTrim Professional Design: Developed by a PebbleTec-certified applicator, TileTrim provides a clean, uniform edge that installs faster and more consistently than traditional methods, enhancing compatibility with Belgard Delmaro Pool Coping for both new constructions and remodels.
- Slurry Saver Efficiency Boost: The innovative formula of Slurry Saver allows contractors to use 20-30% less cement per patch, improving mixing efficiency and reducing material costs, ultimately resulting in smoother finishes and richer colors.









